4.8 Article

Glucocorticoid-Induced Bone Disease

期刊

NEW ENGLAND JOURNAL OF MEDICINE
卷 365, 期 1, 页码 62-70

出版社

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMcp1012926

关键词

-

资金

  1. VA [873765, 5I01BX000436-07] Funding Source: Federal RePORTER
  2. BLRD VA [I01 BX000436] Funding Source: Medline

向作者/读者索取更多资源

A 55-year-old woman with severe, persistent asthma requiring glucocorticoid therapy for the past 3 months presents for care. Her medications include albuterol, inhaled fluticasone with salmeterol, montelukast, and prednisone (at a dose of 10 mg per day). In the past, she received several intermittent courses of prednisone at a dose of 15 mg or more per day. Her weight is 45.5 kg (100 lb), and her height 157.5 cm (62 in.); the body-mass index (the weight in kilograms divided by the square of the height in meters) is 18. Scattered wheezing is heard during expiration. Findings on vertebral percussion and rib-cage compression are unremarkable. How should her case be evaluated and managed to minimize the risk of fractures?

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据